Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

101.91 

1.01 1.0%

as of Feb 15 '19

52 Week Range:

82.74 125.09


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company has a development agreement with scPharmaceuticals Inc. for the development of FUROSCIX, a treatment of edema in patients with heart failure. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 7.51
7.44
8.77
9.39
10.26
10.63
11.92
13.61
13.77
15.63
17.82
growth rate -0.9% 17.9% 7.1% 9.3% 3.6% 12.1% 14.2% 1.2% 13.5% 14.0%
Earnings BIT 86.40
109.50
83.10
74.50
92.70
213.30
249.30
183.30
130.10
226.80
239.20
growth rate 26.7% -24.1% -10.4% 24.4% 130.1% 16.9% -26.5% -29.0% 74.3% 5.5%
Avg.PE 19.69
15.11
18.48
23.15
18.59
24.33
31.15
31.27
49.62
42.78
43.09
growth rate -23.3% 22.3% 25.3% -19.7% 30.9% 28.0% 0.4% 58.7% -13.8% 0.7%
ROA 6.72
7.31
5.95
5.09
5.61
5.45
6.94
7.61
5.68
8.42
8.42
growth rate 8.8% -18.6% -14.5% 10.2% -2.9% 27.3% 9.7% -25.4% 48.2% 0.0%
ROE 15.71
17.69
13.62
10.84
11.79
11.66
13.73
13.64
9.65
13.41
12.57
growth rate 12.6% -23.0% -20.4% 8.8% -1.1% 17.8% -0.7% -29.3% 39.0% -6.3%
ROIC 10.12
11.11
9.24
8.09
8.86
8.50
10.19
10.61
8.05
11.14
10.98
growth rate 9.8% -16.8% -12.5% 9.5% -4.1% 19.9% 4.1% -24.1% 38.4% -1.4%
Cur. Ratio 2.25
2.30
2.32
2.57
1.94
2.13
2.75
2.61
2.14
2.66
2.66
growth rate 2.2% 0.9% 10.8% -24.5% 9.8% 29.1% -5.1% -18.0% 24.3% 0.0%
Quick Ratio 1.45
1.38
1.30
1.39
0.98
1.33
1.79
1.72
1.45
1.67
1.75
growth rate -4.8% -5.8% 6.9% -29.5% 35.7% 34.6% -3.9% -15.7% 15.2% 4.8%
Leverage 2.44
2.40
2.19
2.07
2.14
2.15
1.84
1.75
1.66
1.54
1.46
growth rate -1.6% -8.8% -5.5% 3.4% 0.5% -14.4% -4.9% -5.1% -7.2% -5.2%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 128.60
138.70
126.40
155.10
175.00
185.70
179.00
181.40
200.50
253.20
growth rate 7.9% -8.9% 22.7% 12.8% 6.1% -3.6% 1.3% 10.5% 26.3%
Acct.Payable 154.40
102.90
108.00
103.10
119.80
122.00
138.10
growth rate -33.4% 5.0% -4.5% 16.2% 1.8% 13.2%
Cur.Assets 366.20
397.20
436.60
472.00
557.30
650.70
659.10
673.70
641.90
743.50
growth rate 8.5% 9.9% 8.1% 18.1% 16.8% 1.3% 2.2% -4.7% 15.8%
Total Assets 1,168.70
1,271.00
1,294.30
1,399.10
1,564.00
1,671.60
1,669.70
1,695.10
1,716.70
1,862.80
growth rate 8.8% 1.8% 8.1% 11.8% 6.9% -0.1% 1.5% 1.3% 8.5%
Cash 87.20
83.10
110.20
91.80
161.90
230.00
255.30
274.60
203.00
235.90
growth rate -4.7% 32.6% -16.7% 76.4% 42.1% 11.0% 7.6% -26.1% 16.2%
Inventory 115.70
129.20
147.00
151.80
67.70
72.10
181.50
181.10
199.30
215.20
growth rate 11.7% 13.8% 3.3% -55.4% 6.5% 151.7% -0.2% 10.1% 8.0%
Cur.Liabilities 159.10
171.10
169.70
243.20
261.80
236.90
252.50
314.30
241.00
279.50
growth rate 7.5% -0.8% 43.3% 7.7% -9.5% 6.6% 24.5% -23.3% 16.0%
Liabilities 681.60
691.90
668.60
744.20
835.10
765.20
712.80
671.20
599.20
582.90
growth rate 1.5% -3.4% 11.3% 12.2% -8.4% -6.9% -5.8% -10.7% -2.7%
LT Debt 394.60
382.10
379.10
358.10
299.30
378.80
371.30
311.70
230.90
226.20
197.00
growth rate -3.2% -0.8% -5.5% -16.4% 26.6% -2.0% -16.1% -25.9% -2.0% -12.9%
Equity 485.30
487.10
579.10
625.70
654.90
728.90
906.40
956.90
1,023.90
1,117.50
1,279.90
growth rate 0.4% 18.9% 8.1% 4.7% 11.3% 24.4% 5.6% 7.0% 9.1% 14.5%
Common Shares 72.00
72.00
72.00
73.00
74.00
71.00
71.00
72.00
73.00
75.00
75.00
growth rate 0.0% 0.0% 1.4% 1.4% -4.1% 0.0% 1.4% 1.4% 2.7% 0.0%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 134.10
139.10
107.80
73.80
95.40
131.30
151.90
111.90
131.60
170.20
130.80
growth rate 3.7% -22.5% -31.5% 29.3% 37.6% 15.7% -26.3% 17.6% 29.3% -23.2%
Cash Dividends 17.50
18.60
20.10
21.70
23.20
24.90
26.80
29.10
32.40
35.80
39.10
growth rate 6.3% 8.1% 8.0% 6.9% 7.3% 7.6% 8.6% 11.3% 10.5% 9.2%
Cash From OA 129.20
135.00
137.70
138.30
130.70
187.40
220.50
182.90
212.40
219.40
263.30
growth rate 4.5% 2.0% 0.4% -5.5% 43.4% 17.7% -17.1% 16.1% 3.3% 20.0%
FCF per Share -0.06
0.41
0.88
0.68
0.77
1.06
1.08
1.04
0.64
1.38
growth rate 100.0% 114.6% -22.7% 13.2% 37.7% 1.9% -3.7% -38.5% 115.6%
Sale Purchase of Stock 5.80
-4.70
-5.20
17.10
15.90
29.70
43.90
growth rate -100.0% 0.0% 100.0% -7.0% 86.8% 47.8%
FCF -4.90
-4.00
29.00
65.00
33.00
55.00
65.00
70.00
80.00
49.00
133.00
growth rate 0.0% 100.0% 124.1% -49.2% 66.7% 18.2% 7.7% 14.3% -38.8% 171.4%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 1,020.00
1,051.10
1,055.70
1,104.70
1,192.30
1,266.40
1,368.40
1,421.40
1,399.80
1,509.10
1,599.10
growth rate 3.1% 0.4% 4.6% 7.9% 6.2% 8.1% 3.9% -1.5% 7.8% 6.0%
Op.Income 124.10
97.50
90.70
75.50
80.70
112.30
183.30
130.10
226.80
239.20
growth rate -21.4% -7.0% -16.8% 6.9% 39.2% 63.2% -29.0% 74.3% 5.5%
IBT 109.50
83.10
74.50
92.70
113.40
147.10
174.30
121.90
198.00
231.60
growth rate -24.1% -10.4% 24.4% 22.3% 29.7% 18.5% -30.1% 62.4% 17.0%
Net Income 86.00
72.60
65.30
75.50
80.70
112.30
127.10
95.60
143.60
150.70
growth rate -15.6% -10.1% 15.6% 6.9% 39.2% 13.2% -24.8% 50.2% 4.9%
EPS 1.02
1.25
1.06
0.94
1.08
1.15
1.57
1.75
1.30
1.91
1.99
growth rate 22.6% -15.2% -11.3% 14.9% 6.5% 36.5% 11.5% -25.7% 46.9% 4.2%
Gross Profit 281.70
302.60
303.60
318.10
339.30
464.60
434.70
447.80
455.80
501.10
512.60
growth rate 7.4% 0.3% 4.8% 6.7% 36.9% -6.4% 3.0% 1.8% 9.9% 2.3%
R&D 18.70
19.90
23.90
29.10
33.20
37.90
37.30
34.10
36.80
39.10
growth rate 6.4% 20.1% 21.8% 14.1% 14.2% -1.6% -8.6% 7.9% 6.3%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 63.70
59.70
57.00
62.80
65.10
growth rate -6.3% -4.5% 10.2% 3.7%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 251.80
253.20
290.40
296.70
302.90
growth rate 0.6% 14.7% 2.2% 2.1%
Acct.Payable 121.90
138.10
127.60
126.20
125.20
growth rate 13.3% -7.6% -1.1% -0.8%
Cur.Assets 776.90
743.50
743.50
766.90
850.10
growth rate -4.3% 0.0% 3.2% 10.9%
Total Assets 1,930.40
1,862.80
1,869.60
1,873.70
1,946.10
growth rate -3.5% 0.4% 0.2% 3.9%
Cash 269.30
235.90
199.80
225.50
297.30
growth rate -12.4% -15.3% 12.9% 31.8%
Inventory 215.80
215.20
215.70
208.20
206.80
growth rate -0.3% 0.2% -3.5% -0.7%
Cur.Liabilities 300.00
279.50
263.40
287.60
288.80
growth rate -6.8% -5.8% 9.2% 0.4%
Liabilities 613.50
582.90
564.30
591.80
594.30
growth rate -5.0% -3.2% 4.9% 0.4%
LT Debt 196.60
197.00
198.00
196.40
196.20
growth rate 0.2% 0.5% -0.8% -0.1%
Equity 1,316.90
1,279.90
1,305.30
1,281.90
1,351.80
growth rate -2.8% 2.0% -1.8% 5.5%
Common Shares 18.70
18.80
18.80
18.80
18.80
growth rate 0.5% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 34.30
29.50
28.00
20.20
26.50
growth rate -14.0% -5.1% -27.9% 31.2%
Cash Dividends 9.60
10.40
10.40
10.30
10.30
growth rate 8.3% 0.0% -1.0% 0.0%
Cash From OA 75.80
81.50
45.00
82.00
88.40
growth rate 7.5% -44.8% 82.2% 7.8%
Sale Purchase of Stock 7.50
5.10
5.10
8.20
growth rate -32.0% 0.0% 60.8%
FCF 41.50
52.00
17.00
61.80
61.90
growth rate 25.3% -67.3% 263.5% 0.2%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 398.20
415.60
415.70
447.50
431.70
growth rate 4.4% 0.0% 7.7% -3.5%
Op.Income 63.70
59.70
57.00
62.80
65.10
growth rate -6.3% -4.5% 10.2% 3.7%
IBT 65.00
61.80
56.10
62.10
63.20
growth rate -4.9% -9.2% 10.7% 1.8%
Net Income 51.00
43.60
56.10
55.20
growth rate -7.5% 28.7% -1.6%
EPS
growth rate
Gross Profit 125.00
128.50
134.40
142.20
135.60
growth rate 2.8% 4.6% 5.8% -4.6%
R&D 9.10
9.70
9.60
10.80
10.10
growth rate 6.6% -1.0% 12.5% -6.5%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (76.51)

YOY Growth Grade:

C (52.51)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 49.79 49.79 31.07
EPS / Growth 12.5% 2.05 10.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.2% 11.3% 11.3%
Future PE 20.40 34.48 34.48
Future EPS 5.41 5.97 5.97
Value Price
MOS %
27.26
-73.2%
50.85
-50.1%
50.85
-50.1%
MOS Price 13.63 25.42 25.42
IRT 17.74 16.82 16.82

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.